مقاله‌های دارای تعهدات انتشار عمومی - Claudio Marcocciبیشتر بدانید
جای دیگری دردسترس نیست: ۸
مرور
Effects of selenium on short-term control of hyperthyroidism due to Graves’ disease treated with methimazole: results of a randomized clinical trial‏
M Leo, L Bartalena, G Rotondo Dottore, E Piantanida, P Premoli, I Ionni, ...‏
Journal of endocrinological investigation 40, 281-287, 2017‏
تعهدات: Government of Italy‏
مرور
Cross-cultural validity of the thyroid-specific quality-of-life patient-reported outcome measure, ThyPRO‏
T Watt, G Barbesino, JB Bjorner, SJ Bonnema, B Bukvic, R Drummond, ...‏
Quality of Life Research 24, 769-780, 2015‏
تعهدات: Danish Council for Technology and Innovation‏
مرور
Role of the underlying thyroid disease on the phenotype of Graves' orbitopathy in a tertiary referral center‏
M Leo, F Menconi, R Rocchi, F Latrofa, E Sisti, MA Profilo, B Mazzi, ...‏
Thyroid 25 (3), 347-351, 2015‏
تعهدات: Government of Italy‏
مرور
Total thyroid ablation in Graves’ orbitopathy‏
F Menconi, M Leo, P Vitti, C Marcocci, M Marinò‏
Journal of Endocrinological Investigation 38, 809-815, 2015‏
تعهدات: Government of Italy‏
مرور
Age and dose are major risk factors for liver damage associated with intravenous glucocorticoid pulse therapy for Graves' Orbitopathy‏
E Sisti, B Coco, F Menconi, M Leo, R Rocchi, F Latrofa, MA Profilo, ...‏
Thyroid 25 (7), 846-850, 2015‏
تعهدات: Government of Italy‏
مرور
Long-term outcome of Graves’ orbitopathy following high-dose intravenous glucocorticoids and orbital radiotherapy‏
E Sisti, F Menconi, M Leo, MA Profilo, T Mautone, B Mazzi, R Rocchi, ...‏
Journal of Endocrinological Investigation 38, 661-668, 2015‏
تعهدات: Government of Italy‏
مرور
Renal complications and quality of life in postsurgical hypoparathyroidism: a case–control study‏
L Mazoni, A Matrone, M Apicella, F Saponaro, S Borsari, E Pardi, B Cosci, ...‏
Journal of Endocrinological Investigation, 1-10, 2022‏
تعهدات: Government of Italy‏
مرور
Pseudohypoparathyroidism: focus on cerebral and renal calcifications‏
L Mazoni, M Apicella, F Saponaro, G Mantovani, FM Elli, S Borsari, ...‏
The Journal of Clinical Endocrinology & Metabolism 106 (8), e3005-e3020, 2021‏
تعهدات: Government of Italy‏
جای دیگری دردسترس است: ۳۱
مرور
Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop‏
JP Bilezikian, ML Brandi, R Eastell, SJ Silverberg, R Udelsman, ...‏
The Journal of Clinical Endocrinology & Metabolism 99 (10), 3561-3569, 2014‏
تعهدات: US National Institutes of Health‏
مرور
Skeletal and extraskeletal actions of vitamin D: current evidence and outstanding questions‏
R Bouillon, C Marcocci, G Carmeliet, D Bikle, JH White, ...‏
Endocrine reviews 40 (4), 1109-1151, 2019‏
تعهدات: US National Institutes of Health, US Department of Veterans Affairs, US …‏
مرور
Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus‏
AA Khan, DA Hanley, R Rizzoli, J Bollerslev, JEM Young, L Rejnmark, ...‏
Osteoporosis International 28, 1-19, 2017‏
تعهدات: US National Institutes of Health‏
مرور
Primary hyperparathyroidism‏
JP Bilezikian, NE Cusano, AA Khan, JM Liu, C Marcocci, F Bandeira‏
Nature reviews Disease primers 2 (1), 1-16, 2016‏
تعهدات: US National Institutes of Health‏
مرور
Parathyroid carcinoma‏
C Marcocci, F Cetani, MR Rubin, SJ Silverberg, A Pinchera, JP Bilezikian‏
Journal of Bone and Mineral Research 23 (12), 1869-1880, 2008‏
تعهدات: US National Institutes of Health‏
مرور
Morphometric vertebral fractures in postmenopausal women with primary hyperparathyroidism‏
E Vignali, G Viccica, D Diacinti, F Cetani, L Cianferotti, E Ambrogini, ...‏
The Journal of Clinical Endocrinology & Metabolism 94 (7), 2306-2312, 2009‏
تعهدات: US National Institutes of Health‏
مرور
Graves’ orbitopathy as a rare disease in Europe: a European Group on Graves’ Orbitopathy (EUGOGO) position statement‏
P Perros, L Hegedüs, L Bartalena, C Marcocci, GJ Kahaly, L Baldeschi, ...‏
Orphanet journal of rare diseases 12, 1-6, 2017‏
تعهدات: National Institute for Health Research, UK‏
مرور
Cinacalcet reduces serum calcium concentrations in patients with intractable primary hyperparathyroidism‏
C Marcocci, P Chanson, D Shoback, J Bilezikian, L Fernandez-Cruz, ...‏
The Journal of Clinical Endocrinology & Metabolism 94 (8), 2766-2772, 2009‏
تعهدات: US National Institutes of Health‏
مرور
Teprotumumab efficacy, safety, and durability in longer-duration thyroid eye disease and re-treatment: OPTIC-X study‏
RS Douglas, GJ Kahaly, S Ugradar, H Elflein, KA Ponto, BT Fowler, ...‏
Ophthalmology 129 (4), 438-449, 2022‏
تعهدات: US National Institutes of Health, Federal Ministry of Education and Research …‏
مرور
Spontaneous improvement of untreated mild Graves' ophthalmopathy: Rundle's curve revisited‏
F Menconi, MA Profilo, M Leo, E Sisti, MA Altea, R Rocchi, F Latrofa, ...‏
Thyroid 24 (1), 60-66, 2014‏
تعهدات: Government of Italy‏
مرور
CDC73 mutational status and loss of parafibromin in the outcome of parathyroid cancer‏
F Cetani, C Banti, E Pardi, S Borsari, P Viacava, P Miccoli, L Torregrossa, ...‏
Endocrine connections 2 (4), 186-195, 2013‏
تعهدات: Government of Italy‏
مرور
Unmet therapeutic, educational and scientific needs in parathyroid disorders‏
J Bollerslev, C Schalin-Jäntti, L Rejnmark, H Siggelkow, H Morreau, ...‏
European journal of endocrinology 181 (3), P1-P19, 2019‏
تعهدات: National Institute for Health Research, UK, Wellcome Trust‏
اطلاعات انتشارات و تأمین بودجه به‌طورخودکار توسط برنامه رایانه‌ای تعیین می‌شود.